Atara Biotherapeutics, Inc.

NasdaqGS:ATRA 株式レポート

時価総額：US$40.9m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Atara Biotherapeutics マネジメント

マネジメント 基準チェック /34

Atara Biotherapeutics'の CEO はPascal Touchonで、 Jun2019年に任命され、 の在任期間は 5.08年です。 の年間総報酬は$ 4.38Mで、 16.5%給与と83.5%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.48%を直接所有しており、その価値は$ 196.77K 。経営陣と取締役会の平均在任期間はそれぞれ3.5年と6.9年です。

主要情報

Pascal Touchon

最高経営責任者

US$4.4m

報酬総額

CEO給与比率16.5%
CEO在任期間5.1yrs
CEOの所有権0.5%
経営陣の平均在職期間3.5yrs
取締役会の平均在任期間6.9yrs

経営陣の近況

Recent updates

New Forecasts: Here's What Analysts Think The Future Holds For Atara Biotherapeutics, Inc. (NASDAQ:ATRA)

May 14
New Forecasts: Here's What Analysts Think The Future Holds For Atara Biotherapeutics, Inc. (NASDAQ:ATRA)

Revenues Working Against Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Share Price Following 26% Dive

May 11
Revenues Working Against Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Share Price Following 26% Dive

Atara Biotherapeutics: Opportunity As They Sell Off Their Approved Asset For Longer Runway

Feb 06

Here's Why Atara Biotherapeutics (NASDAQ:ATRA) Must Use Its Cash Wisely

Oct 17
Here's Why Atara Biotherapeutics (NASDAQ:ATRA) Must Use Its Cash Wisely

Earnings Working Against Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Share Price Following 32% Dive

May 18
Earnings Working Against Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Share Price Following 32% Dive

Need To Know: Analysts Are Much More Bullish On Atara Biotherapeutics, Inc. (NASDAQ:ATRA)

Feb 13
Need To Know: Analysts Are Much More Bullish On Atara Biotherapeutics, Inc. (NASDAQ:ATRA)

Analysts Have Just Cut Their Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Revenue Estimates By 16%

Nov 22
Analysts Have Just Cut Their Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Revenue Estimates By 16%

EMA panel backs approval of Atara's Ebvallo for transplant complication

Oct 14

Atara Bio to get additional $30M milestone payment under collaboration with Pierre Fabre

Sep 28

Atara: 2 Possible Regulatory Approvals For Tab-Cel, Plus CAR T Pipeline

Aug 17

Atara adds 16% ahead of Phase 2 data for multiple sclerosis candidate

Jul 12

Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Intrinsic Value Is Potentially 42% Above Its Share Price

Jul 03
Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) Intrinsic Value Is Potentially 42% Above Its Share Price

Time To Worry? Analysts Just Downgraded Their Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Outlook

May 11
Time To Worry? Analysts Just Downgraded Their Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Outlook

CEO報酬分析

Atara Biotherapeutics の収益と比較して、Pascal Touchon の報酬はどのように変化したか？
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$233m

Dec 31 2023US$4mUS$723k

-US$276m

Sep 30 2023n/an/a

-US$286m

Jun 30 2023n/an/a

-US$305m

Mar 31 2023n/an/a

-US$215m

Dec 31 2022US$5mUS$718k

-US$228m

Sep 30 2022n/an/a

-US$247m

Jun 30 2022n/an/a

-US$248m

Mar 31 2022n/an/a

-US$350m

Dec 31 2021US$5mUS$681k

-US$340m

Sep 30 2021n/an/a

-US$328m

Jun 30 2021n/an/a

-US$318m

Mar 31 2021n/an/a

-US$311m

Dec 31 2020US$5mUS$655k

-US$307m

Sep 30 2020n/an/a

-US$304m

Jun 30 2020n/an/a

-US$301m

Mar 31 2020n/an/a

-US$298m

Dec 31 2019US$7mUS$319k

-US$291m

報酬と市場: Pascalの 総報酬 ($USD 4.38M ) は、 US市場 ($USD 667.63K ) の同規模の企業の平均を上回っています。

報酬と収益: Pascalの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Pascal Touchon (61 yo)

5.1yrs

在職期間

US$4,375,125

報酬

Dr. Pascal Touchon, D.V.M., serves as Independent Director at Ipsen S.A. since October 4, 2023. He has been President, Chief Executive Officer and Director at Atara Biotherapeutics, Inc. since June 24, 201...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Pascal Touchon
President5.1yrsUS$4.38m0.48%
$ 196.8k
Anhco Nguyen
Executive VP and Chief Scientific & Technical Officer3.2yrsUS$2.28m0.19%
$ 79.0k
K. Murugan
Executive VP & Chief Legal Officer4.3yrsUS$2.31m0.18%
$ 74.0k
Eric Hyllengren
Executive VP & Chief Financial Officer1.3yrsデータなし0.15%
$ 61.3k
Alex Chapman
Vice President of Corporate Communications & Investor Relationsno dataデータなしデータなし
Jill Henrich
Executive VP and Global Head of Regulatory Affairs & Quality3.8yrsデータなし0.12%
$ 49.9k
Dan Maziasz
Executive VP & Chief Business Officer3.5yrsデータなしデータなし
Rajani Dinavahi
Senior VP & Chief Medical Officerless than a yearデータなしデータなし

3.5yrs

平均在職期間

51yo

平均年齢

経験豊富な経営陣: ATRAの経営陣は 経験豊富 であると考えられます ( 3.4年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Pascal Touchon
President5.1yrsUS$4.38m0.48%
$ 196.8k
William Heiden
Independent Director8.7yrsUS$237.23k0.13%
$ 51.7k
Matthew Fust
Independent Director10.3yrsUS$239.73k0.043%
$ 17.7k
Carol Gallagher
Chairman & Lead Independent Director11.5yrsUS$260.23k0.35%
$ 143.7k
Ameet Mallik
Independent Director2.9yrsUS$219.52k0.017%
$ 7.0k
Maria Roncarolo
Independent Director4.2yrsUS$229.73k0.026%
$ 10.7k

6.9yrs

平均在職期間

60yo

平均年齢

経験豊富なボード: ATRAの 取締役会 は 経験豊富 であると考えられます ( 8.6年の平均在任期間)。